[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

@article{Haioun200518Ffluoro2deoxyDglucosePE,
  title={[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.},
  author={Corinne Haioun and Emmanuel Itti and Alain Rahmouni and Pauline Brice and J. D. Rain and Karim Belhadj and Philippe Gaulard and Laurent Garderet and Eric Lepage and F. Moncada Reyes and Michel 6 Meignan},
  journal={Blood},
  year={2005},
  volume={106 4},
  pages={1376-81}
}
Assessment of early therapeutic response using metabolic imaging is potentially useful to determine prognosis in aggressive lymphoma. Between January 2000 and January 2004, 90 patients with newly diagnosed aggressive lymphoma (median age 53 years, 94% diffuse large B-cell) were prospectively explored with [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) prior to induction chemotherapy, after 2 cycles ("early PET"), and after induction completion. Therapeutic response was… CONTINUE READING